Company Overview
ALT5 Sigma Corporation operates within the Technology sector, specifically focusing on the Software - Application industry, where it delivers blockchain-powered technologies globally through its Fintech and Biotechnology segments. The company engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets, offering a suite of products designed for these specialized financial functions. Its market capitalization stands at $170.56M, while the organization employs approximately 10 individuals to support its operational structure and technological development. These valuation and revenue figures indicate a mid-sized market presence within the software application space, suggesting the company is navigating a competitive landscape with a relatively small workforce but significant revenue generation capabilities relative to its headcount.
Financial Health
The company reported revenue of $24.89M for the trailing twelve months, accompanied by a net income of $33.67M and an EBITDA of $-18,142,000. The substantial gap between the positive net income and the negative EBITDA reveals a distinct cost structure where non-operating income or interest income significantly boosts the bottom line despite negative earnings before interest, taxes, depreciation, and amortization. Free cash flow stands at $-10,371,375, indicating that the company is currently consuming cash to fund operations or investments, which limits immediate financial flexibility for dividends or aggressive share buybacks. Gross margin is calculated at 43.5%, reflecting the high proportion of revenue remaining after deducting the cost of goods sold for its software and technology services. In contrast, the operating margin is reported at -218.3%, a figure that suggests significant operating expenses or a specific accounting treatment regarding interest and other non-operating items are affecting the standard operating profitability metric. Profit margin, however, is listed at 133.1%, demonstrating that the company generates more net income than its total revenue, a scenario often driven by significant non-operating gains or interest income. The company holds $7.32M in cash against $17.81M in total debt, resulting in a debt-to-equity ratio of 1.14, which characterizes a leveraged balance sheet where liabilities exceed the equity base. The current ratio is 0.80, indicating that the company possesses fewer current assets than current liabilities, which signals potential short-term liquidity pressure in meeting its immediate obligations. Return on equity is 4.3%, while return on assets is -1.7%, metrics that collectively reveal challenges in generating returns from the shareholder's capital and the company's asset base given the negative EBITDA and the specific composition of its income statement.
Valuation Assessment
The trailing P/E ratio is listed as N/A, and the forward P/E is also N/A, implying that standard earnings-based valuation multiples cannot be reliably calculated or are not applicable due to the specific earnings structure or data availability for this reporting period. The price-to-book ratio is 0.11, which indicates that the market values the company at a fraction of its book value, suggesting a significant discount relative to the accounting value of its assets. The price-to-sales ratio is 6.85, a metric that suggests the market is willing to pay a premium for each dollar of sales, potentially reflecting high growth expectations or the strategic value of its blockchain assets. The EV/EBITDA stands at -11.31, which serves as an alternative valuation metric that is negative, further highlighting the impact of negative EBITDA on traditional enterprise value calculations. The 52-week high is $10.95 and the 52-week low is $1.08; without a specific current price provided in the facts, the positioning relative to this range cannot be numerically calculated, but the range demonstrates substantial volatility within the reporting period. The beta value is 1.95, which indicates that the stock price is expected to be nearly twice as volatile as the broader market, reflecting higher sensitivity to market fluctuations and sector-specific risks.
Growth & Income
Revenue growth year-over-year is recorded at 53.3%, while earnings growth year-over-year is listed as N/A. The absence of a calculable earnings growth rate relative to the strong revenue expansion implies that the growth in net income may not be keeping pace with revenue or is subject to significant variance in non-operating items. Regarding income distribution, the company has a dividend yield of N/A and a payout ratio of 0.0%, indicating that it does not currently distribute earnings to shareholders. This 0.0% payout ratio suggests that the company reinvests its earnings, or rather its positive net income, back into the business for growth initiatives rather than paying dividends to investors. The overall growth and income profile is characterized by strong revenue expansion of 53.3% combined with a lack of dividend distribution, focusing capital retention for operational scaling within the Fintech and Biotechnology segments.